Please enable Javascript in your Browser to experience full features of this website.
AIDSinfo Logo
AIDS
info
Mobile
|
1-800-HIV-0440
|
Contact Us
|
En Español
Search Here:
skip navigation
Home
Guidelines
Antiretroviral Treatment
Adult and Adolescent ARV Guidelines
Pediatric ARV Guidelines
Maternal-Child Transmission
Perinatal Guidelines
Management of HIV Complications
Adult and Adolescent OI Prevention and Treatment Guidelines
Pediatric OI Prevention and Treatment Guidelines
Care for Disaster Displaced HIV-Infected Patients
Guidelines on Care for HIV-Infected Residents Displaced from Disaster Areas
Preexposure Prophylaxis
Preexposure Prophylaxis (PrEP) Guidelines
Postexposure Prophylaxis
Occupational Postexposure Prophylaxis (PEP) Guidelines
Nonoccupational Postexposure Prophylaxis (nPEP) Guidelines
Prevention
HIV Counseling, Testing, and Referral Guidelines
Guidelines on Incorporating HIV Prevention into Medical Care
Search the Guidelines
Please Select a Guideline
Adult and Adolescent Guidelines
Pediatric Guidelines
Perinatal Guidelines
Search Guidelines
Clinical Trials
Clinical Trials Search Options
Search by Keyword
Search by Category
Select a topic
Cancer
Coinfections
Complications/Side Effects
Opportunistic Infections
Prevention Research
Specific Populations
Treatment Research
Vaccine Research
Trials by Age
Trials by Study Type
Search by Topics
Select a subtopic
Advanced Search
Download Education Materials
What is an HIV/AIDS Clinical Trial (PDF)
Preventive HIV Vaccines (PDF)
Therapeutic HIV Vaccines (PDF)
Drugs
FDA-approved
Combination Drugs
Entry and Fusion Inhibitors
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Opportunistic Infections
Protease Inhibitors
Investigational
Entry and Fusion Inhibitors
Integrase Inhibitors
Non-nucleoside Reverse Transcriptase Inhibitors
Nucleoside Reverse Transcriptase Inhibitors
Search HIV/AIDS Drugs
Alphabetical Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Drugs
HIV/AIDS Health Topics
HIV/AIDS-Related Guidelines
Staying Healthy with HIV
Specific Populations
Treatment Resources
HIV/AIDS-Related Conditions
Prevention Research
General Information
Clinical Research
For Health Care Providers
For Researchers
Search HIV/AIDS Health Topics
Alphabetical Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Topics
Education Materials
Glossary
HIV and Its Treatment Fact Sheet (PDF)
Pregnancy Fact Sheet (PDF)
More Fact Sheets
HIV/AIDS Awareness Day Pages
Search the Glossary
(Other Education Materials not included)
Alphabetical Glossary Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All Glossary Terms
Mobile Resources & Tools
Mobile Site
Apps
APIs
Widgets
Order Publications
Skip Nav
Drugs News
Home
>
Drugs
> Drugs News
Small
Medium
Large
Text Size
FDA Updates Atazanavir Sulfate Capsule Labeling with Adverse Reaction and Drug Interaction Information
Date: February 4, 2013
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm339009.htm
FDA Updates Darunavir Tablet and Oral Suspension Labeling with Pediatric Dosing Information
Date: February 1, 2013
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm337778.htm
FDA Updates Complera Label with New Indication and Clinical Trial Information
Date: January 25, 2013
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm337007.htm
FDA Updates Lopinavir/Ritonavir Labeling to Include New Drug Interaction Information
Date: January 22, 2013
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm336367.htm
FDA Approves First Anti-Diarrheal Drug for Individuals with HIV/AIDS
Date: December 31, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1317/fda-approves-first-anti-diarrheal-drug-for-individuals-with-hiv-aids/
FDA Updates Rilpivirine Label with New Indication and Clinical Trial Data
Date: December 10, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm331574.htm
FDA Updates Adefovir Dipivoxil Label with Safety Information on Stribild
Date: November 30, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm330240.htm
HIV Treatment Reduces Risk of Malaria Recurrence in Children
Date: November 28, 2012
Source: National Institutes of Health (NIH) - no specific institute
http://aidsinfo.nih.gov/news/1306/hiv-treatment-reduces-risk-of-malaria-recurrence-in-children/
FDA Releases Draft Guidance on Vaginal Microbicides for the Prevention of HIV
Date: November 26, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm329466.htm
FDA Approves 800-mg Tablet Strength for Darunavir
Date: November 14, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm328097.htm
FDA Updates Label for Nevirapine to Include New 100-mg Tablet, Dosing Information in Children
Date: November 14, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm328098.htm
AIDS
info
Launches Redesigned Drug Database
Date: September 28, 2012
Source: AIDS
info
http://aidsinfo.nih.gov/drugs/
NIH-Funded Analysis Estimates Effective PrEP Dosing
Date: September 13, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/1279/nih-funded-analysis-estimates-effective-prep-dosing/
FDA Approves New Combination Pill for HIV Treatment for Some Individuals
Date: August 27, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1275/fda-approves-new-combination-pill-for-hiv-treatment-for-some-individuals/
CDC Issues Interim Guidance on Use of Medication to Prevent HIV Infection
Date: August 9, 2012
Source: Centers for Disease Control and Prevention (CDC)
Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)
http://aidsinfo.nih.gov/news/1269/cdc-issues-interim-guidance-on-use-of-medication-to-prevent-hiv-infection/
HPTN 052 Study Demonstrates Additional Health Benefits, Cost-Effectiveness
Date: July 27, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/1266/hptn-052-study-demonstrates-additional-health-benefits-cost-effectiveness/
NIH to Test Dapivirine Vaginal Ring for HIV Prevention in Women
Date: July 24, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/1260/nih-to-test-dapivirine-vaginal-ring-for-hiv-prevention-in-women/
NIH Scientists to Test Maraviroc-Based Drug Regimens for HIV Prevention
Date: July 18, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/1257/nih-scientists-to-test-maraviroc-based-drug-regimens-for-hiv-prevention/
CDC Statement on FDA Approval of Truvada for HIV Prevention
Date: July 16, 2012
Source: Centers for Disease Control and Prevention (CDC)
Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)
http://aidsinfo.nih.gov/news/1256/cdc-statement-on-fda-approval-of-truvada-for-hiv-prevention/
FDA Approves First Drug (Truvada) for Reducing the Risk of HIV Infection
Date: July 16, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1254/fda-approves-first-drug-(truvada)-for-reducing-the-risk-of-hiv-infection/
Adding Nevirapine to HIV Regimen Halves Newborn Transmission Rate
Date: June 20, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Child Health and Human Development (NICHD)
http://aidsinfo.nih.gov/news/1251/adding-nevirapine-to-hiv-regimen-halves-newborn-transmission-rate/
FDA Approves Generic Formulation of Abacavir Tablets
Date: June 19, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm309085.htm
FDA Launches New Website with Information on the Development of Microbicides
Date: June 7, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/InvestigationalNewDrugINDApplication/Overview/ucm077763.htm
FDA Updates Darunavir Label with Safety Information
Date: June 1, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm306449.htm
FDA Approves Generic Formulations of Nevirapine
Date: May 24, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm305654.htm
FDA Approves Generic Formulation of Lamivudine and Zidovudine Tablets
Date: May 23, 2012
Source: Food and Drug Administration (FDA)
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm305490.htm
Anti-HIV Drug Use During Pregnancy Does Not Affect Infant Size, Birth Weight
Date: May 1, 2012
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/1232/anti-hiv-drug-use-during-pregnancy-does-not-affect-infant-size-birth-weight/
FDA Approves New Pediatric Dosing Recommendations for Fosamprenavir
Date: April 30, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1231/fda-approves-new-pediatric-dosing-recommendations-for-fosamprenavir/
FDA Issues Safety Announcement on Interactions Between Boceprevir and Certain PIs
Date: April 26, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1230/fda-issues-safety-announcement-on-interactions-between-boceprevir-and-certain-pis/
FDA Approves New Pediatric Dosing Recommendations for Etravirine
Date: March 26, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1223/fda-approves-new-pediatric-dosing-recommendations-for-etravirine/
FDA Expands Use of Isentress to Children & Adolescents
Date: December 21, 2011
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/919/fda-expands-use-of-isentress-to-children--adolescents/
Short Course INH-RPT in Patients Taking ARVs
Date: December 20, 2011
http://aidsinfo.nih.gov/contentfiles/Short_Course_INH-RPT.pdf
Cholesterol Levels Elevated In Toddlers Taking Anti-HIV Drugs
Date: November 21, 2011
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/915/cholesterol-levels-elevated-in-toddlers-taking-anti-hiv-drugs/
Isentress (raltegravir) package insert updated
Date: November 2, 2011
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm278378.htm
Supplemental Information Regarding the Role of Rilpivirine (RPV) as Initial Therapy - August 16, 2011
Date: August 16, 2011
http://aidsinfo.nih.gov/contentfiles/NNRTI_One_Page_Info-RPV.pdf
Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination - August 10, 2011
Date: August 10, 2011
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/909/approval-of-complera-emtricitabine-rilpivirine-tenofovir-df-fixed-dose-combination---august-10-2011/
Fluconazole and birth defects - chronic use in pregnancy (outside of vaginal candidiasis) now FDA pregnancy class D - August 4, 2011
Date: August 4, 2011
http://aidsinfo.nih.gov/contentfiles/Fluconazole_FDA_Drug_Safety.pdf
CDC Trial and Another Major Study Find PrEP Can Reduce Risk of HIV Infection among Heterosexuals - July 13, 2011
Date: July 13, 2011
Source: Centers for Disease Control and Prevention (CDC)
Author: National Center for HIV, STD, and TB Prevention (NCHHSTP)
http://aidsinfo.nih.gov/news/907/cdc-trial-and-another-major-study-find-prep-can-reduce-risk-of-hiv-infection-among-heterosexuals---july-13-2011/
Approval of generic formulation of lamivudine and zidovudine tablets, 150 mg/300 mg - May 25, 2011
Date: May 25, 2011
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/903/approval-of-generic-formulation-of-lamivudine-and-zidovudine-tablets-150-mg-300-mg---may-25-2011/
Approval of Edurant (rilpivirine), a new NNRTI, for the Treatment of HIV in Treatment Naive Patients - May 20, 2011
Date: May 20, 2011
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm256151.htm
Treating HIV-infected People with Antiretrovirals Protects Partners from Infection - May 12, 2011
Date: May 12, 2011
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/901/treating-hiv-infected-people-with-antiretrovirals-protects-partners-from-infection---may-12-2011/
Update to Fuzeon (enfuvirtide) label regarding incidence of bacterial pneumonia - April 28, 2011
Date: April 28, 2011
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm253417.htm
The FEM-PrEP HIV Prevention Study and Its Implications for NIAID Research - April 18, 2011
Date: April 18, 2011
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/899/the-fem-prep-hiv-prevention-study-and-its-implications-for-niaid-research---april-18-2011/
NIH Study Examines Best Time for Healthy HIV-infected People to Begin Antiretrovirals - March 7, 2011
Date: March 7, 2011
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/896/nih-study-examines-best-time-for-healthy-hiv-infected-people-to-begin-antiretrovirals---march-7-2011/
Safety Review update of Abacavir: no statistically significant association seen between myocardial infarction and ABC - March 1, 2011
Date: March 1, 2011
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm245247.htm
Kaletra (lopinavir/ritonavir) Oral Solution label changes related to toxicity in preterm neonates - February 24, 2011
Date: February 24, 2011
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm244639.htm
Viracept (nelfinavir) Label change reflects drug-drug interaction information with warfarin - February 24, 2011
Date: February 24, 2011
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm244619.htm
New Intelence (etravirine) dosage approved - December 22, 2010
Date: December 22, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm238057.htm
FDA approves Egrifta to treat Lipodystrophy in HIV patients - November 10, 2010
Date: November 10, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/889/fda-approves-egrifta-to-treat-lipodystrophy-in-hiv-patients---november-10-2010/
FDA Approves Egrifta to Treat Lipodystrophy in HIV Patients - November 10, 2010
Date: November 10, 2010
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm233516.htm
NIH Network Identifies Better Treatment Regimen for HIV-Infected Infants - November 3, 2010
Date: November 3, 2010
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/888/nih-network-identifies-better-treatment-regimen-for-hiv-infected-infants---november-3-2010/
FDA Drug Safety Communication: Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms - October 21, 2010
Date: October 21, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/887/fda-drug-safety-communication-invirase-(saquinavir)-labels-now-contain-updated-risk-information-on-abnormal-heart-rhythms---october-21-2010/
Invirase (saquinavir) labels now contain updated risk information on abnormal heart rhythms - October 21, 2010
Date: October 21, 2010
http://www.fda.gov/Drugs/DrugSafety/ucm230096.htm#safety/
FDA Drug Safety Communication: New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients
Date: September 15, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/881/fda-drug-safety-communication-new-dosing-recommendations-to-prevent-potential-valcyte-(valganciclovir)-overdose-in-pediatric-transplant-patients/
New dosing recommendations to prevent potential Valcyte (valganciclovir) overdose in pediatric transplant patients - September 15, 2010
Date: September 15, 2010
http://www.fda.gov/Drugs/DrugSafety/ucm225727.htm
NIH-Funded Study Finds Early HAART during TB Treatment Boosts Survival Rate in People Co-Infected with HIV and TB - July 22, 2010
Date: July 22, 2010
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/880/nih-funded-study-finds-early-haart-during-tb-treatment-boosts-survival-rate-in-people-co-infected-with-hiv-and-tb---july-22-2010/
NIH Scientist Anthony S. Fauci to Address Early HIV Infection and a Novel Target for HIV Vaccine Development - July 20, 2010
Date: July 20, 2010
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/879/nih-scientist-anthony-s-fauci-to-address-early-hiv-infection-and-a-novel-target-for-hiv-vaccine-development---july-20-2010/
Increased Use of Treatment Leads to Reduction in New Diagnoses
Date: July 18, 2010
Source: National Institutes of Health (NIH)
Author: National Institute on Drug Abuse (NIDA)
http://aidsinfo.nih.gov/news/877/increased-use-of-treatment-leads-to-reduction-in-new-diagnoses/
Isentress (raltegravir potassium) label update reflects 96 week safety/efficacy results in treatment-naive and treatment-experienced patients - June 30, 2010
Date: June 30, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm217750.htm
Isentress (raltegravir potassium) label update reflects 96 week safety/efficacy results in treatment-naive and treatment-experienced patients
Date: June 29, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/872/isentress-(raltegravir-potassium)-label-update-reflects-96-week-safety-efficacy-results-in-treatment-naive-and-treatment-experienced-patients/
Selzentry (maraviroc) labeling changes for patients with renal impairment
Date: May 27, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/873/selzentry-(maraviroc)-labeling-changes-for-patients-with-renal-impairment/
New Kaletra (lopinavir/ritonavir) Tablets and Oral Solution once daily dosing regimen in certain adult patients
Date: April 28, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/864/new-kaletra-(lopinavir-ritonavir)-tablets-and-oral-solution-once-daily-dosing-regimen-in-certain-adult-patients/
New Kaletra (lopinavir/ritonavir) Tablets and Oral Solution once daily dosing regimen in certain adult patients - April 28, 2010
Date: April 28, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm209940.htm
New label information affecting all approved protease inhibitors for treatment of HIV
Date: April 27, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/863/new-label-information-affecting-all-approved-protease-inhibitors-for-treatment-of-hiv/
Updated label information for Sustiva (efavirenz)
Date: April 14, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/865/updated-label-information-for-sustiva-(efavirenz)/
Intelence (etravirine) label revised to include new drug-drug interaction information - March 11, 2010
Date: March 11, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm204217.htm
Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms - February 23, 2010
Date: February 23, 2010
http://aidsinfo.nih.gov/news/1068/ongoing-safety-review-of-invirase-(saquinavir)-and-possible-association-with-abnormal-heart-rhythms---february-23-2010/
Kaletra (lopinavir/ritonavir) package insert revision regarding drug-drug interaction information - February 1, 2010
Date: February 1, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm199270.htm
FDA Drug Safety Communication: Serious liver disorder associated with the use of Videx/Videx EC (didanosine)
Date: January 29, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/857/fda-drug-safety-communication-serious-liver-disorder-associated-with-the-use-of-videx-videx-ec-(didanosine)/
Serious Liver Disorder Associated with the use of Videx/Videx EC (didanosine) - January 29, 2010
Date: January 29, 2010
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm199169.htm
Prezista (darunavir) labeling changes reflect 96 week study data - January 27, 2010
Date: January 28, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm199204.htm
Atripla label update reflects new efficacy, safety and resistance data in treatment experienced patients - January 7, 2010
Date: January 8, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm196950.htm
Important information about Lexiva (fosamprenavir calcium) Tablets and Oral Suspension - December 4, 2009
Date: December 4, 2009
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm192905.htm
Tenofovir/ Emtricitabine Performs Better than Abacavir/ Lamivudine in Subgroup of Antiretroviral-Naïve, HIV-Infected Individuals - December 2, 2009
Date: December 2, 2009
http://www3.niaid.nih.gov/news/newsreleases/2009/TenofovirEmtricitabine.htm
Tenofovir/Emtricitabine Performs Better than Abacavir/Lamivudine in Subgroup of Antiretroviral-Naïve, HIV-Infected Individuals
Date: December 1, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/851/tenofovir-emtricitabine-performs-better-than-abacavir-lamivudine-in-subgroup-of-antiretroviral-naïve-hiv-infected-individuals/
Intelence (etravirine) label updated to reflect dosing data through 48 weeks - 25 November, 2009
Date: November 25, 2009
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm192039.htm
Expanded indication for Selzentry (maraviroc) - November 24, 2009
Date: November 24, 2009
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm191962.htm
Important label update for Norvir (ritonavir) - November 24, 2009
Date: November 24, 2009
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm191853.htm
New dosing recommendations Retrovir (zidovudine) syrup for HIV-infected infants - November 10, 2009
Date: November 11, 2009
http://aidsinfo.nih.gov/news/1167/new-dosing-recommendations-retrovir-(zidovudine)-syrup-for-hiv-infected-infants---november-10-2009/
FDA Issues a Safety Warning for Etravirine - August 26, 2009
Date: August 26, 2009
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm180480.htm
Starting Antiretroviral Therapy Earlier Yields Better Clinical Outcomes : Interim Review Leads to Early End of Clinical Trial in Haiti
Date: June 8, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/836/starting-antiretroviral-therapy-earlier-yields-better-clinical-outcomes--interim-review-leads-to-early-end-of-clinical-trial-in-haiti/
IL-2 Immunotherapy Fails to Benefit HIV-Infected Individuals Already Taking Antiretrovirals
Date: February 10, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/824/il-2-immunotherapy-fails-to-benefit-hiv-infected-individuals-already-taking-antiretrovirals/
Anti-HIV Gel Shows Promise in Large-scale Study in Women
Date: February 9, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/826/anti-hiv-gel-shows-promise-in-large-scale-study-in-women/
Anti-HIV `Drug Cocktails¿ Equally Effective in Patients with or without History of Injection Drug Use
Date: August 6, 2008
Source: National Institutes of Health (NIH)
Author: National Institute on Drug Abuse (NIDA)
http://aidsinfo.nih.gov/news/819/anti-hiv-`drug-cocktails¿-equally-effective-in-patients-with-or-without-history-of-injection-drug-use/
NIDA: HAART Equally Effective in Patients with or without History of Injection Drug Use - August 6, 2008
Date: August 6, 2008
http://www.nih.gov/news/health/aug2008/nida-06.htm
Dear Healthcare Professional Letter Issued: Important Information for Prescribers about Viracept (Nelfinavir) - May 9, 2008
Date: May 9, 2008
http://aidsinfo.nih.gov/contentfiles/NFV_prescribing_info.pdf
Adult Guidelines Panel Issues a Communication on Abacavir - April 4, 2008
Date: April 4, 2008
http://aidsinfo.nih.gov/contentfiles/ABCComm.pdf
FDA Approves New NNRTI, Etravirine - January 18, 2008
Date: January 24, 2008
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124019.htm
FDA Approves New HIV Drug After Priority Review
Date: January 18, 2008
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/807/fda-approves-new-hiv-drug-after-priority-review/
FDA Approves the First Integrase Inhibitor, Raltegravir - October 12, 2007
Date: October 12, 2007
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/803/fda-approves-the-first-integrase-inhibitor-raltegravir---october-12-2007/
FDA Antiviral Drugs Advisory Committee Recommends Accelerated Approval of Raltegravir - September 5, 2007
Date: September 26, 2007
http://www.cdcnpin.org/scripts/display/NewsDisplay.asp?NewsNbr=49021
DHHS Perinatal Panel Notice on Nelfinavir FDA-Pfizer Letter - September 11, 2007
Date: September 11, 2007
http://aidsinfo.nih.gov/contentfiles/PeriNFVNotice1.pdf
HIV Protease Inhibitors Show Potential as Cancer Treatments
Date: September 1, 2007
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/801/hiv-protease-inhibitors-show-potential-as-cancer-treatments/
FDA Approves HIV-Entry Inhibitor Maraviroc - August 6, 2007
Date: August 7, 2007
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm124198.htm
Approval of maraviroc
Date: August 6, 2007
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/800/approval-of-maraviroc/
Treating HIV-Infected Infants Early Helps Them Live Longer
Date: July 25, 2007
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/798/treating-hiv-infected-infants-early-helps-them-live-longer/
FDA approval of Lexiva oral suspension and label changes for pediatric patients and patients with hepatic impairment
Date: June 18, 2007
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/796/fda-approval-of-lexiva-oral-suspension-and-label-changes-for-pediatric-patients-and-patients-with-hepatic-impairment/
NIDA Looks at Non-Injection Drug Use and Spread of HIV/AIDS
Date: May 8, 2007
Source: National Institutes of Health (NIH)
Author: National Institute on Drug Abuse (NIDA)
http://aidsinfo.nih.gov/news/794/nida-looks-at-non-injection-drug-use-and-spread-of-hiv-aids/
FDA Advisory Committee Recommends Accelerated Approval of HIV Entry Inhibitor, Maraviroc - April 24, 2007
Date: April 27, 2007
http://www.aidsinfo.nih.gov/ListServ/PreviewPage.aspx?pageID=28
FDA Grants Tentative Approval to Generic Formulation of Stavudine - April 24, 2007
Date: April 24, 2007
http://www.fda.gov/oashi/aids/listserve/listserve2007.html#042307/
Product Labeling for Kaletra (lopinavir/ritonavir) Updated with New Safety and Efficacy Data - April 24th, 2007
Date: April 24, 2007
http://www.fda.gov/oashi/aids/listserve/listserve2007.html#42307/
Important Notice about Combivir and Ziagen
Date: April 10, 2007
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/791/important-notice-about-combivir-and-ziagen/
FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)-March 9, 2007
Date: March 9, 2007
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01582.html
NIH Release--New Paradigm Will Help Identify Leads for Drug Discovery--July 24, 2006
Date: February 6, 2007
http://aidsinfo.nih.gov/news/938/nih-release--new-paradigm-will-help-identify-leads-for-drug-discovery--july-24-2006/
NIH Release--Women's Response to Anti-HIV Therapy Improved If Treatment Begins Six Months After Earlier Preventive RegimenResponse to Treatment Diminished If Treatment Begins Within Six Months Of Preventive Regimen, January 10, 2007
Date: January 10, 2007
http://www.nichd.nih.gov/news/releases/nevirapine_therapy.cfm
WOMEN'S RESPONSE TO ANTI-HIV THERAPY IMPROVED IF TREATMENT BEGINS SIX MONTHS AFTER EARLIER PREVENTIVE REGIMEN
Date: January 10, 2007
Source: National Institutes of Health (NIH)
Author: Office of the Director (OD) of NIH
http://aidsinfo.nih.gov/news/781/womens-response-to-anti-hiv-therapy-improved-if-treatment-begins-six-months-after-earlier-preventive-regimen/
International HIV/AIDS Trial Finds that Risks of Death, AIDS and Other Major Diseases Increase on Episodic Antiretroviral Therapy
Date: November 29, 2006
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/780/international-hiv-aids-trial-finds-that-risks-of-death-aids-and-other-major-diseases-increase-on-episodic-antiretroviral-therapy/
Atazanavir Labeling Changes
Date: November 27, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/750/atazanavir-labeling-changes/
Food and Drug Administration Approved New 300 mg Capsule Form of Reyataz--October 16, 2006
Date: October 16, 2006
http://aidsinfo.nih.gov/contentfiles/FDA-10_25_06-New300mgReyatazApproved.pdf
Tentative approval of lamivudine/zidovudine copackaged with abacavir sulfate
Date: July 26, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/771/tentative-approval-of-lamivudine-zidovudine-copackaged-with-abacavir-sulfate/
FDA Approves the First Once-a-Day Three-Drug Combination Tablet for Treatment of HIV-1
Date: July 12, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/769/fda-approves-the-first-once-a-day-three-drug-combination-tablet-for-treatment-of-hiv-1/
FDA Grants Tentative Approval of a Three-Component AIDS Drug
Date: June 30, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/768/fda-grants-tentative-approval-of-a-three-component-aids-drug/
Important safety information about Aptivus ( tipranavir)
Date: June 30, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/767/important-safety-information-about-aptivus-(-tipranavir)/
FDA Approves New HIV Treatment for Patients Who Do Not Respond to Existing Drugs
Date: June 27, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/764/fda-approves-new-hiv-treatment-for-patients-who-do-not-respond-to-existing-drugs/
FDA Gives Tentative Approval for Another First Time Generic Pediatric AIDS Drug in Association with the President's Emergency Plan for AIDS Relief
Date: June 27, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/765/fda-gives-tentative-approval-for-another-first-time-generic-pediatric-aids-drug-in-association-with-the-presidents-emergency-plan-for-aids-relief/
FDA Approval of Prezista
Date: June 26, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/763/fda-approval-of-prezista/
FDA Approval of Prezista--June 26, 2006
Date: June 26, 2006
http://www.fda.gov/bbs/topics/NEWS/2006/NEW01395.html
FDA--GARDASIL: Questions and Answers--June 8, 2006
Date: June 12, 2006
http://www.fda.gov/cber/products/hpvmer060806qa.htm
FDA Release--New Guidance on Antiviral Product Development--June 9, 2006
Date: June 9, 2006
http://aidsinfo.nih.gov/ContentFiles/FDA-6_8_06.pdf
AIDS Drugs Have Saved 3 Million Years of Life in the United States--NIH Press Release, June 2, 2006
Date: June 7, 2006
http://www3.niaid.nih.gov/news/newsreleases/2006/AIDSsurvival.htm
Generic zidovudine in Capsule Form
Date: March 31, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/757/generic-zidovudine-in-capsule-form/
FDA Grants Traditional Approval of Viread and Truvada--March 8, 2006
Date: March 14, 2006
http://aidsinfo.nih.gov/ContentFiles/FDA-3_14_06.pdf
Traditional Approval of Viread and Truvada
Date: March 8, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/755/traditional-approval-of-viread-and-truvada/
FDA Label Changes for Atazanavir--January 30, 2006
Date: January 30, 2006
http://aidsinfo.nih.gov/ContentFiles/SummaryLabelChangesAtazanavir.pdf
FDA Announces New Prescription Drug Information Format to Improve Patient Safety--January 19, 2006
Date: January 20, 2006
http://aidsinfo.nih.gov/ContentFiles/FDA-NewPresDrugImprovePatientSafety.pdf
International HIV/AIDS Trial Finds Continuous Antiretroviral Therapy Superior to Episodic Therapy
Date: January 18, 2006
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/748/international-hiv-aids-trial-finds-continuous-antiretroviral-therapy-superior-to-episodic-therapy/
Strategies for Management of Anti-Retroviral Therapy (SMART) Trial Q & A's--January 18, 2006
Date: January 18, 2006
http://aidsinfo.nih.gov/ContentFiles/SMART_trial_ends_early_QA.pdf
FDA approves New Formulation of Kaletra--October 28, 2005
Date: November 1, 2005
http://aidsinfo.nih.gov/other/2FDA-10_31_05.pdf
FDA approval of new formulation of Kaletra
Date: October 28, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/745/fda-approval-of-new-formulation-of-kaletra/
Emtriva: New Formulation and Labeling Changes
Date: September 29, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/741/emtriva-new-formulation-and-labeling-changes/
FDA Approves First Pediatric Generic AIDS Drug for U.S. Marketing
Date: September 19, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/740/fda-approves-first-pediatric-generic-aids-drug-for-us-marketing/
Tentative Approval Generic Zidovudine Oral Solution
Date: September 7, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/737/tentative-approval-generic-zidovudine-oral-solution/
FDA Approval of Aptivus (tipranavir)
Date: June 21, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/731/fda-approval-of-aptivus-(tipranavir)/
FDA Tentatively Approves First Generic Nevirapine under the President's Emergency Plan for AIDS Relief
Date: June 20, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/732/fda-tentatively-approves-first-generic-nevirapine-under-the-presidents-emergency-plan-for-aids-relief/
FDA Tentatively Approves a Generic AIDS Drug under the President's Emergency Plan for AIDS Relief
Date: June 15, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/733/fda-tentatively-approves-a-generic-aids-drug-under-the-presidents-emergency-plan-for-aids-relief/
FDA Approves Generic Version of Foscavir
Date: May 31, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/730/fda-approves-generic-version-of-foscavir/
Dear Health Care Provider Letter Regarding the Discontinuation of Fortovase
Date: May 26, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/729/dear-health-care-provider-letter-regarding-the-discontinuation-of-fortovase/
FDA Approved the use of KALETRA, Once-daily Administration for the Treatment of HIV-infection in Therapy-naïve Adults--April 29,2005
Date: April 29, 2005
http://www.aidsinfo.nih.gov/other/FDAKaletra.pdf
FDA Approves Once-Daily Dosage of Kaletra for Therapy-Naïve Adult Patients
Date: April 29, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/728/fda-approves-once-daily-dosage-of-kaletra-for-therapy-naïve-adult-patients/
Important Change in SUSTIVA (efavirenz) Package Insert — Change from Pregnancy Category C to D--March 31, 2005
Date: April 1, 2005
#/##
FDA Public Health Advisory for Nevirapine (Viramune)-January 19, 2005
Date: January 19, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/723/fda-public-health-advisory-for-nevirapine-(viramune)-january-19-2005/
New 500 mg Tablet Formulation of Invirase (saquinavir) Approved
Date: December 21, 2004
http://www.fda.gov/oashi/aids/listserve/listserve2004.html#invir500/
New information about coadministration of REYATAZ (atazanavir) and Norvir (ritonavir) with Prilosec (omeprazole) - December 20, 2004
Date: December 20, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/722/new-information-about-coadministration-of-reyataz-(atazanavir)-and-norvir-(ritonavir)-with-prilosec-(omeprazole)---december-20-2004/
FDA approves generic formulation of didanosine (ddI) delayed release capsules
Date: December 3, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/721/fda-approves-generic-formulation-of-didanosine-(ddi)-delayed-release-capsules/
Treating Opportunistic Infections Among HIV-Exposed and Infected Children - November 23, 2004
Date: December 3, 2004
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5314a1.htm
Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents - December 17, 2004
Date: December 3, 2004
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm
FDA Approves Sculptra for HIV Patients
Date: August 3, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/709/fda-approves-sculptra-for-hiv-patients/
FDA Approves Two Fixed-Dose Combination Drug Products For the Treatment of HIV-1 Infection
Date: August 2, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/710/fda-approves-two-fixed-dose-combination-drug-products-for-the-treatment-of-hiv-1-infection/
Researchers Identify Better Hepatitis C Treatment for People with HIV
Date: July 19, 2004
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/708/researchers-identify-better-hepatitis-c-treatment-for-people-with-hiv/
Weekly Cycles of Once-Daily Anti-Drugs Could Reduce Cost of HIV Treatment
Date: May 24, 2004
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/704/weekly-cycles-of-once-daily-anti-drugs-could-reduce-cost-of-hiv-treatment/
HHS Proposes Rapid Process For Review of Fixed Dose Combination and Co-Packaged Products
Date: May 16, 2004
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/705/hhs-proposes-rapid-process-for-review-of-fixed-dose-combination-and-co-packaged-products/
Label Changes for Crixivan - May 2004
Date: May 13, 2004
http://www.fda.gov/cder/foi/label/2004/20685slr046,047_crixivan_lbl.pdf
Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products for Treatment of HIV
Date: May 1, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/703/guidance-for-industry-fixed-dose-combination-and-co-packaged-drug-products-for-treatment-of-hiv/
HIV Patients Get Long-Term Boost with Short, Intermittent Drug Regimen
Date: April 26, 2004
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/702/hiv-patients-get-long-term-boost-with-short-intermittent-drug-regimen/
Joint Statement Issued Regarding Principles For Fixed-Dose Combination Drug Products
Date: April 8, 2004
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/701/joint-statement-issued-regarding-principles-for-fixed-dose-combination-drug-products/
FDA Issues Draft Guidance on Providing More Information on Investigational Treatment
Date: January 27, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/692/fda-issues-draft-guidance-on-providing-more-information-on-investigational-treatment/
Drug errors involving Keppra and Kaletra
Date: January 12, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/690/drug-errors-involving-keppra-and-kaletra/
Combination, Order of Anti-HIV Drugs Make a Difference in First-time Recipients
Date: December 10, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/685/combination-order-of-anti-hiv-drugs-make-a-difference-in-first-time-recipients/
Revisions to Kaletra (lopinavir/ritonavir) labeling
Date: December 9, 2003
http://www.fda.gov/cder/foi/label/2003/21226slr012,21251slr009_kaletra_lbl.pdf
FDA Approves LEXIVA (Fosamprenavir calcium) to Treat HIV Infection
Date: October 21, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/682/fda-approves-lexiva-(fosamprenavir-calcium)-to-treat-hiv-infection/
Drug Warning: Once-daily Triple NRTI Regimen containing Didanosine, Lamivudine, and Tenofovir
Date: October 14, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/681/drug-warning-once-daily-triple-nrti-regimen-containing-didanosine-lamivudine-and-tenofovir/
New Live Attenuated Influenza Vaccine (FluMist) Not Recommended for People with HIV or their Close Contacts
Date: October 9, 2003
http://aidsetc.org/aidsetc?page=et-02-00-03
Nevirapine Sustains Advantage Over AZT During Breastfeeding Period
Date: September 11, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/676/nevirapine-sustains-advantage-over-azt-during-breastfeeding-period/
Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection
Date: August 27, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/675/treatment-interruption-shows-no-benefit-in-drug-resistant-hiv-infection/
Important New Pharmacokinetic Data for REYATAZ(tm) (atazanavir sulfate) in combination with Viread® (tenofovir disoproxil fumarate)
Date: August 8, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/674/important-new-pharmacokinetic-data-for-reyataz(tm)-(atazanavir-sulfate)-in-combination-with-viread®-(tenofovir-disoproxil-fumarate)/
CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection
Date: July 31, 2003
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/673/cdc-recommendations-against-the-use-of-rifampin-and-pyrazinamide-for-treatment-of-latent-tuberculosis-infection/
Revised Guidelines Will Ease Selection of HIV/AIDS Treatments
Date: July 14, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/677/revised-guidelines-will-ease-selection-of-hiv-aids-treatments/
FDA Approves a Once Daily Protease Inhibitor for HIV Infection
Date: June 20, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/669/fda-approves-a-once-daily-protease-inhibitor-for-hiv-infection/
Discovery Lays Groundwork for Potential New Class of Anti-HIV Drugs
Date: March 31, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/661/discovery-lays-groundwork-for-potential-new-class-of-anti-hiv-drugs/
FDA Approves First Drug in New Class of HIV Treatments
Date: March 13, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/655/fda-approves-first-drug-in-new-class-of-hiv-treatments/
Important Interim Results from a Phase III, Randomized, Double-Blind Comparison of Three Protease-Inhibitor-Sparing Regimens for the Initial Treatment of HIV Infection (AACTG Protocol A5095)
Date: March 13, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/656/important-interim-results-from-a-phase-iii-randomized-double-blind-comparison-of-three-protease-inhibitor-sparing-regimens-for-the-initial-treatment-of-hiv-infection-(aactg-protocol-a5095)/
FDA Proposes New Warning for Over-The-Counter Contraceptive Drugs Containing Nonoxynol-9
Date: January 16, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/648/fda-proposes-new-warning-for-over-the-counter-contraceptive-drugs-containing-nonoxynol-9/
Preventive Therapy for Non-Occupational Exposures
Date: January 1, 2003
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/659/preventive-therapy-for-non-occupational-exposures/
Food and Drug Administration approved a new, extended release formulation of ZERIT
Date: December 31, 2002
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/646/food-and-drug-administration-approved-a-new-extended-release-formulation-of-zerit/
Bush Administration will Seek New Legislation for Mandatory Pediatric Drug Testing
Date: December 16, 2002
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/645/bush-administration-will-seek-new-legislation-for-mandatory-pediatric-drug-testing/
Study Sheds Light on Cause of an AIDS Treatment Side Effect
Date: September 12, 2002
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/629/study-sheds-light-on-cause-of-an-aids-treatment-side-effect/
Majority of HIV-Infected Mothers and At-Risk Newborns Receive ZDV Treatment in Groundbreaking Thailand Prevention Program
Date: July 6, 2002
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/624/majority-of-hiv-infected-mothers-and-at-risk-newborns-receive-zdv-treatment-in-groundbreaking-thailand-prevention-program/
Study Concludes Benefits of Anti-HIV Therapy During Pregnancy Outweigh Risks
Date: June 12, 2002
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/608/study-concludes-benefits-of-anti-hiv-therapy-during-pregnancy-outweigh-risks/
Garlic Supplements Can Impede HIV Medication
Date: December 5, 2001
Source: National Institutes of Health (NIH)
Author: Warren Grant Magnusen Clinical Center
http://aidsinfo.nih.gov/news/584/garlic-supplements-can-impede-hiv-medication/
7-Day-On, 7-Day-Off Regimen Could Reduce Cost, Toxicities of HIV Therapy
Date: December 3, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/582/7-day-on-7-day-off-regimen-could-reduce-cost-toxicities-of-hiv-therapy/
New Finding May Help Doctors Prevent HIV Drug Resistance
Date: November 22, 2001
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/580/new-finding-may-help-doctors-prevent-hiv-drug-resistance/
FDA Approves Viread for HIV-1 Infection
Date: October 29, 2001
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/576/fda-approves-viread-for-hiv-1-infection/
Use of Antifungal Drug Fluconazole Effective in Preventing Thrush in Persons Who are HIV Positive
Date: April 24, 2001
Source: Agency for Healthcare Research and Quality (AHRQ)
http://aidsinfo.nih.gov/news/553/use-of-antifungal-drug-fluconazole-effective-in-preventing-thrush-in-persons-who-are-hiv-positive/
FDA/Bristol Myers Squibb Issues Caution for HIV Combination Therapy with Zerit and Videx in Pregnant Women
Date: January 5, 2001
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/549/fda-bristol-myers-squibb-issues-caution-for-hiv-combination-therapy-with-zerit-and-videx-in-pregnant-women/
FDA Approves Trizivir for HIV
Date: November 15, 2000
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/544/fda-approves-trizivir-for-hiv/
Interleukin-2 May Help Patients With Advanced HIV Disease, New Study Shows
Date: October 25, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/542/interleukin-2-may-help-patients-with-advanced-hiv-disease-new-study-shows/
Shorter AZT Treatment Reduces Mother to Child HIV Transmission As Well As Longer Treatment But For Less Cost
Date: October 4, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Child Health and Human Development (NICHD)
http://aidsinfo.nih.gov/news/541/shorter-azt-treatment-reduces-mother-to-child-hiv-transmission-as-well-as-longer-treatment-but-for-less-cost/
FDA Approves Kaletra for HIV Infection
Date: September 15, 2000
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/539/fda-approves-kaletra-for-hiv-infection/
Statement from Claude Lenfant, M.D., Director, National Heart, Lung, & Blood Institute, on AZT and Cardiac Damage in Infants
Date: September 13, 2000
Source: National Institutes of Health (NIH)
Author: National Heart, Blood and Lung Institute (NHLBI)
http://aidsinfo.nih.gov/news/538/statement-from-claude-lenfant-md-director-national-heart-lung--blood-institute-on-azt-and-cardiac-damage-in-infants/
Inexpensive AIDS Drug Still Reduces HIV Transmission from Mother to Child After One Year
Date: July 13, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/535/inexpensive-aids-drug-still-reduces-hiv-transmission-from-mother-to-child-after-one-year/
UPDATE ON CLINICAL TRIALS OF INTERLEUKIN-2 (IL-2) AS IMMUNE-BASED THERAPY FOR HIV
Date: July 8, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/531/update-on-clinical-trials-of-interleukin-2-(il-2)-as-immune-based-therapy-for-hiv/
NIAID Topical Microbicide Research Developing New Tools to Protect Women from HIV/AIDS and Other STDs
Date: March 1, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/345/niaid-topical-microbicide-research-developing-new-tools-to-protect-women-from-hiv-aids-and-other-stds/
NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort and an HIV Protease Inhibitor
Date: February 10, 2000
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/519/nih-clinical-center-study-demonstrates-dangerous-interaction-between-st-johns-wort-and-an-hiv-protease-inhibitor/
NIAID Study: Rapid Rebound of HIV and Reappearance of HIV Reservoirs in Patients Treated with IL-2 and Combination Antiretroviral Drugs Following Cessation of Therapy
Date: October 27, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/512/niaid-study-rapid-rebound-of-hiv-and-reappearance-of-hiv-reservoirs-in-patients-treated-with-il-2-and-combination-antiretroviral-drugs-following-cessation-of-therapy/
New Model Suggests That AIDS Drugs May Not Abolish HIV Infection
Date: October 6, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/511/new-model-suggests-that-aids-drugs-may-not-abolish-hiv-infection/
Researchers Identify a Simple, Affordable Drug Regimen That is Highly Effective in Preventing HIV Infection in Infants of Mothers with the Disease
Date: July 14, 1999
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/496/researchers-identify-a-simple-affordable-drug-regimen-that-is-highly-effective-in-preventing-hiv-infection-in-infants-of-mothers-with-the-disease/
Attacking AIDS with a 'Cocktail' Therapy: Drug Combo Sends Deaths Plummeting
Date: July 1, 1999
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/493/attacking-aids-with-a-cocktail-therapy-drug-combo-sends-deaths-plummeting/
Scientists Suggest New Approaches for Development of AIDS Drugs and Vaccines
Date: June 21, 1999
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/492/scientists-suggest-new-approaches-for-development-of-aids-drugs-and-vaccines/
New Anti-HIV Therapies Needed To Eradicate HIV
Date: May 26, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/489/new-anti-hiv-therapies-needed-to-eradicate-hiv/
FDA Approves Amprenavir for HIV Infection
Date: April 16, 1999
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/479/fda-approves-amprenavir-for-hiv-infection/
Reassuring Findings About Infants Exposed to Zidovudine
Date: January 12, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/465/reassuring-findings-about-infants-exposed-to-zidovudine/
FDA Approves Abacavir for HIV-1 Infection
Date: December 18, 1998
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/463/fda-approves-abacavir-for-hiv-1-infection/
Protease Inhibitors May Increase Blood Glucose in HIV Patients
Date: December 1, 1998
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/421/protease-inhibitors-may-increase-blood-glucose-in-hiv-patients/
Treatment With IL-2 Plus HAART Markedly Reduces HIV in Immune System 'Hiding Places'
Date: November 15, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/451/treatment-with-il-2-plus-haart-markedly-reduces-hiv-in-immune-system-hiding-places/
Information About the Safety of Combination Antiretroviral Treatment for Human Immunodeficiency Virus Infection During Pregnancy
Date: October 15, 1998
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/454/information-about-the-safety-of-combination-antiretroviral-treatment-for-human-immunodeficiency-virus-infection-during-pregnancy/
Study Shows Efavirenz Promising in Treating Pediatric HIV Infection: Leads to Approval of New Drug for Treating HIV-infected Children
Date: September 28, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/442/study-shows-efavirenz-promising-in-treating-pediatric-hiv-infection-leads-to-approval-of-new-drug-for-treating-hiv-infected-children/
Scientist Report New Strategy to Rapidly Assess Effectiveness of AIDS Drugs in Children
Date: September 22, 1998
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/445/scientist-report-new-strategy-to-rapidly-assess-effectiveness-of-aids-drugs-in-children/
FDA Approves New Drug to Treat HIV, AIDS
Date: September 18, 1998
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/443/fda-approves-new-drug-to-treat-hiv-aids/
The Perils of Discontinuing Therapy: Without HAART, Cytokines Stimulate HIV From Latently Infected Cells
Date: July 6, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/426/the-perils-of-discontinuing-therapy-without-haart-cytokines-stimulate-hiv-from-latently-infected-cells/
Short Course of AZT Given Late in Pregnancy and During Delivery Contributes to Reducing Mother-to-Child HIV Transmission
Date: June 29, 1998
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/436/short-course-of-azt-given-late-in-pregnancy-and-during-delivery-contributes-to-reducing-mother-to-child-hiv-transmission/
Interleukin-12 Helps Control Mycobacterium Avium Infection
Date: June 1, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/417/interleukin-12-helps-control-mycobacterium-avium-infection/
Short-Course Regimen of AZT Proven Effective in Reducing Perinatal HIV Transmission: Offers Hope for Reducing Mother-to-Child HIV Transmission in Developing World
Date: February 18, 1998
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/409/short-course-regimen-of-azt-proven-effective-in-reducing-perinatal-hiv-transmission-offers-hope-for-reducing-mother-to-child-hiv-transmission-in-developing-world/
Statement by Donna E. Shalala, Secretary of Health and Human Services, Regarding Findings of Thailand Study of 'Short Course' AZT.
Date: February 18, 1998
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/410/statement-by-donna-e-shalala-secretary-of-health-and-human-services-regarding-findings-of-thailand-study-of-short-course-azt/
Short-Course TB Prophylaxis Effective in HIV-Infected Individuals
Date: February 11, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/408/short-course-tb-prophylaxis-effective-in-hiv-infected-individuals/
3-D Structure of HIV Components May Pave the Way for New Anti-AIDS Drugs
Date: January 15, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of General Medical Sciences (NIGMS)
http://aidsinfo.nih.gov/news/401/3-d-structure-of-hiv-components-may-pave-the-way-for-new-anti-aids-drugs/
FDA Approves New Formulation of First Protease Inhibitor Saquinavir
Date: November 7, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/393/fda-approves-new-formulation-of-first-protease-inhibitor-saquinavir/
FDA Approves First Combination Drug for AIDS
Date: September 29, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/388/fda-approves-first-combination-drug-for-aids/
New Side Effects of Popular AIDS Drug Reported
Date: July 14, 1997
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/379/new-side-effects-of-popular-aids-drug-reported/
TB Prophylaxis Unnecessary in HIV-Infected People with Anergy, Study Suggests
Date: June 30, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/381/tb-prophylaxis-unnecessary-in-hiv-infected-people-with-anergy-study-suggests/
Two Drugs Better Than One for Treating Children with Symptomatic HIV
Date: June 26, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/376/two-drugs-better-than-one-for-treating-children-with-symptomatic-hiv/
Approved Therapies for HIV/AIDS or AIDS-related Conditions
Date: June 17, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/364/approved-therapies-for-hiv-aids-or-aids-related-conditions/
Study Of Low-dose Oral Alpha Interferon Closes
Date: June 13, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/369/study-of-low-dose-oral-alpha-interferon-closes/
Diabetes and Hyperglycemia in Patients Receiving Protease Inhibitors
Date: June 11, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/380/diabetes-and-hyperglycemia-in-patients-receiving-protease-inhibitors/
Health Advisory For Newest Class Of Aids Drugs
Date: June 11, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/366/health-advisory-for-newest-class-of-aids-drugs/
CDC Statement On Post-exposure Prophylaxis For Exposures To HIV
Date: June 10, 1997
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/367/cdc-statement-on-post-exposure-prophylaxis-for-exposures-to-hiv/
CDC Studies of AZT to Prevent Mother-to-Child HIV Transmission in Developing Countries
Date: June 1, 1997
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/363/cdc-studies-of-azt-to-prevent-mother-to-child-hiv-transmission-in-developing-countries/
Combination Drug Therapy for AIDS Found to Control Blinding Eye Infection
Date: May 20, 1997
Source: National Institutes of Health (NIH)
Author: National Eye Institute (NEI)
http://aidsinfo.nih.gov/news/357/combination-drug-therapy-for-aids-found-to-control-blinding-eye-infection/
Study Shows That Doxil is Highly Effective and Safe in the Treatment of Advanced Kaposi's Sarcoma
Date: May 20, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/456/study-shows-that-doxil-is-highly-effective-and-safe-in-the-treatment-of-advanced-kaposis-sarcoma/
Grapefruit Juice Study May Aid Drug Safety
Date: May 14, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of General Medical Sciences (NIGMS)
http://aidsinfo.nih.gov/news/355/grapefruit-juice-study-may-aid-drug-safety/
NIAID Evaluates N-9 Film as Microbicide
Date: April 3, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/344/niaid-evaluates-n-9-film-as-microbicide/
IL-2 Injections Safely Boost CD4+ T Cell Levels in HIV-Infected Patients
Date: March 24, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/340/il-2-injections-safely-boost-cd4--t-cell-levels-in-hiv-infected-patients/
FDA Approves First Protease Inhibitors With Labeling for Use in Children
Date: March 14, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/335/fda-approves-first-protease-inhibitors-with-labeling-for-use-in-children/
FDA Proposes New Use Initiative
Date: March 13, 1997
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/336/fda-proposes-new-use-initiative/
Scientists to Discuss Chemokine Receptor Research
Date: January 23, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/328/scientists-to-discuss-chemokine-receptor-research/
Summary of the Meeting of a Panel to Review Studies of Transplacental Toxicity of AZT
Date: January 14, 1997
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/330/summary-of-the-meeting-of-a-panel-to-review-studies-of-transplacental-toxicity-of-azt/
New ACTG 076 Analysis Emphasizes Importance of Offering AZT Therapy to All HIV-Infected Pregnant Women
Date: November 27, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/20/new-actg-076-analysis-emphasizes-importance-of-offering-azt-therapy-to-all-hiv-infected-pregnant-women/
Important Information on the Combination of Zidovudine (ZDV) and Stavudine (d4T) in ZDV-experienced HIV-Infected Patients
Date: November 22, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/28/important-information-on-the-combination-of-zidovudine-(zdv)-and-stavudine-(d4t)-in-zdv-experienced-hiv-infected-patients/
IL-2 Therapy Doubles CD4+ T Cell Counts in HIV-Infected People
Date: October 30, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/314/il-2-therapy-doubles-cd4--t-cell-counts-in-hiv-infected-people/
Notice to Readers: Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin
Date: October 25, 1996
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/316/notice-to-readers-clinical-update-impact-of-hiv-protease-inhibitors-on-the-treatment-of-hiv-infected-tuberculosis-patients-with-rifampin/
Drug Combo Safe for HIV-Infected Children
Date: September 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/321/drug-combo-safe-for-hiv-infected-children/
Interleukin-2 Continues to Show Promise as HIV Therapy
Date: September 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/317/interleukin-2-continues-to-show-promise-as-hiv-therapy/
Nevirapine Approved by FDA: First non-nucleoside reverse transcriptase inhibitor
Date: September 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/322/nevirapine-approved-by-fda-first-non-nucleoside-reverse-transcriptase-inhibitor/
Volunteers Sought for HIV Treatment Study
Date: September 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/318/volunteers-sought-for-hiv-treatment-study/
FDA Approves Drug for AIDS Wasting
Date: August 23, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/312/fda-approves-drug-for-aids-wasting/
NIH-Sponsored Study Stopped: New Drug Does Not Control AIDS-Related Eye Disease
Date: August 15, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/225/nih-sponsored-study-stopped-new-drug-does-not-control-aids-related-eye-disease/
TB Increases HIV Replication in HIV-Infected People
Date: August 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/296/tb-increases-hiv-replication-in-hiv-infected-people/
Important Therapeutic Information on the Dosing of Clarithromycin for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in HIV-Infected Patients
Date: July 23, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/291/important-therapeutic-information-on-the-dosing-of-clarithromycin-for-the-treatment-of-disseminated-mycobacterium-avium-complex-(dmac)-infection-in-hiv-infected-patients/
Fluconazole Prevents Yeast Infections in Women with HIV
Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/285/fluconazole-prevents-yeast-infections-in-women-with-hiv/
IL-2 Therapy: Encouraging Data on Quality of Life Reported for Immune-Boosting Drug
Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/286/il-2-therapy-encouraging-data-on-quality-of-life-reported-for-immune-boosting-drug/
Interleukin-2 Injections Produce Dramatic, Sustained Increases in CD4+ T Cell Counts in Patients with Early-Stage HIV Disease
Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/288/interleukin-2-injections-produce-dramatic-sustained-increases-in-cd4--t-cell-counts-in-patients-with-early-stage-hiv-disease/
NIAID Study Rules Out High-Dose Clarithromycin for AIDS-Related MAC
Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/287/niaid-study-rules-out-high-dose-clarithromycin-for-aids-related-mac/
The Protease Inhibitors
Date: July 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/298/the-protease-inhibitors/
FDA Approves Cidofovir for AIDS-Related Retinitis
Date: June 27, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/276/fda-approves-cidofovir-for-aids-related-retinitis/
FDA Approves Nevirapine to Treat HIV
Date: June 24, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/290/fda-approves-nevirapine-to-treat-hiv/
Antiretrovirals Plus Immunomodulators: Didanosine/Interferon-alpha Combination Shows Promise
Date: June 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/293/antiretrovirals-plus-immunomodulators-didanosine-interferon-alpha-combination-shows-promise/
Expanded Access and Expedited Approval of New Therapies Related to HIV/AIDS
Date: June 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/269/expanded-access-and-expedited-approval-of-new-therapies-related-to-hiv-aids/
An FDA Guide to Choosing Medical Treatments
Date: May 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/255/an-fda-guide-to-choosing-medical-treatments/
Low-Dose Oral Alpha Interferon Study Opens
Date: April 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/240/low-dose-oral-alpha-interferon-study-opens/
Two New Protease Inhibitors Approved By FDA: NIAID Research Was Pivotal to Development of New Class of Drugs
Date: April 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/247/two-new-protease-inhibitors-approved-by-fda-niaid-research-was-pivotal-to-development-of-new-class-of-drugs/
FDA Grants Accelerated Approval To Third Protease Inhibitor To Treat HIV
Date: March 14, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/233/fda-grants-accelerated-approval-to-third-protease-inhibitor-to-treat-hiv/
FDA Panel Recommends Approval of Third Protease Inhibitor
Date: March 8, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/232/fda-panel-recommends-approval-of-third-protease-inhibitor/
FDA Approves Second Protease Inhibitor to Treat HIV
Date: March 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/231/fda-approves-second-protease-inhibitor-to-treat-hiv/
Where Do HIV/AIDS Drugs Come From?
Date: February 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/72/where-do-hiv-aids-drugs-come-from?/
Two-Drug Treatment is Effective Against Recurrent Eye Infection in AIDS Patients
Date: January 11, 1996
Source: National Institutes of Health (NIH)
Author: National Eye Institute (NEI)
http://aidsinfo.nih.gov/news/306/two-drug-treatment-is-effective-against-recurrent-eye-infection-in-aids-patients/
FDA Approves First Protease Inhibitor Drug for Treatment of HIV
Date: December 7, 1995
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/215/fda-approves-first-protease-inhibitor-drug-for-treatment-of-hiv/
FDA Grants Accelerated Approval for 3TC with AZT to Treat AIDS
Date: November 20, 1995
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/203/fda-grants-accelerated-approval-for-3tc-with-azt-to-treat-aids/
Drug Completely Protects Monkeys Exposed to SIV
Date: November 16, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/202/drug-completely-protects-monkeys-exposed-to-siv/
FDA Panel Recommends Approval of New AIDS Drug
Date: November 15, 1995
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/204/fda-panel-recommends-approval-of-new-aids-drug/
FDA Panel Recommends Approval of 3TC with AZT to Treat AIDS
Date: November 7, 1995
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/201/fda-panel-recommends-approval-of-3tc-with-azt-to-treat-aids/
Thalidomide Effective Treatment for AIDS-Related Mouth Ulcers
Date: October 31, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/200/thalidomide-effective-treatment-for-aids-related-mouth-ulcers/
NIAID Expands Research on Topical Microbicides to Prevent STDs in Women
Date: April 27, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/186/niaid-expands-research-on-topical-microbicides-to-prevent-stds-in-women/
Therapies for AIDS-Related Infections--Two Studies Published
Date: March 14, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/183/therapies-for-aids-related-infections--two-studies-published/
Interleukin-2 Produces Significant, Sustained Increases in CD4+ T Cells in HIV-Infected People
Date: March 1, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/180/interleukin-2-produces-significant-sustained-increases-in-cd4--t-cells-in-hiv-infected-people/
Questions and Answers about the NIAID Interleukin-2 Study
Date: March 1, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/181/questions-and-answers-about-the-niaid-interleukin-2-study/
Toxoplasmosis
Date: March 1, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/139/toxoplasmosis/
ARAC Reaffirms Need for Low-Dose Oral Alpha Interferon Study
Date: February 24, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/182/arac-reaffirms-need-for-low-dose-oral-alpha-interferon-study/
Interim Results Lead to Discontinuation of AZT-Only Study Arm
Date: February 13, 1995
Source: Department of Health and Human Services (DHHS)
Author: Public Health Service (PHS)
http://aidsinfo.nih.gov/news/167/interim-results-lead-to-discontinuation-of-azt-only-study-arm/
Oral Ganciclovir Approved
Date: December 22, 1994
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/195/oral-ganciclovir-approved/
Treatment IND for AIDS-related Wasting Authorized
Date: December 21, 1994
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/194/treatment-ind-for-aids-related-wasting-authorized/
NIAID Trial of Triple Drug Combination for HIV Infection Closes
Date: November 1, 1994
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/158/niaid-trial-of-triple-drug-combination-for-hiv-infection-closes/
AZT Approved for Preventing Maternal-Fetal HIV Transmission
Date: August 8, 1994
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/137/azt-approved-for-preventing-maternal-fetal-hiv-transmission/
Questions and Answers for Publication of 'Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus'
Date: August 5, 1994
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/148/questions-and-answers-for-publication-of-recommendations-of-the-us-public-health-service-task-force-on-the-use-of-zidovudine-to-reduce-perinatal-transmission-of-human-immunodeficiency-virus/
Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus
Date: August 5, 1994
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/144/recommendations-of-the-us-public-health-service-task-force-on-the-use-of-zidovudine-to-reduce-perinatal-transmission-of-human-immunodeficiency-virus/
FDA Approval of Stavudine (d4T)
Date: June 27, 1994
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/116/fda-approval-of-stavudine-(d4t)/
Task Force to Study Implications of AZT in Pregnancy
Date: May 10, 1994
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/121/task-force-to-study-implications-of-azt-in-pregnancy/
Effectiveness in Disease and Injury Prevention: Zidovudine for the Prevention of HIV Transmission from Mother to Infant
Date: April 29, 1994
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/143/effectiveness-in-disease-and-injury-prevention-zidovudine-for-the-prevention-of-hiv-transmission-from-mother-to-infant/
Important Therapeutic Information on the Benefit of Zidovudine for the Prevention of the Transmission of HIV from Mother to Infant
Date: February 22, 1994
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/103/important-therapeutic-information-on-the-benefit-of-zidovudine-for-the-prevention-of-the-transmission-of-hiv-from-mother-to-infant/
AZT Reduces Rate of Maternal Transmission of HIV
Date: February 21, 1994
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/99/azt-reduces-rate-of-maternal-transmission-of-hiv/
FDA Licenses IGIV For Two New Indications
Date: January 3, 1994
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/268/fda-licenses-igiv-for-two-new-indications/
Trimetrexate Approved For Treatment of PCP
Date: December 20, 1993
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/97/trimetrexate-approved-for-treatment-of-pcp/
Fluconazole Delays Fungal Infections In AIDS Patients
Date: December 15, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/95/fluconazole-delays-fungal-infections-in-aids-patients/
Primary Therapy Prevents Initial Bout of PCP
Date: December 15, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/96/primary-therapy-prevents-initial-bout-of-pcp/
AIDSTRIALS and AIDSDRUGS
Date: October 1, 1993
Source: National Library of Medicine (NLM)
http://aidsinfo.nih.gov/news/309/aidstrials-and-aidsdrugs/
Two Studies Examine Drugs to Prevent HIV-Associated Opportunistic Infections
Date: July 26, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/67/two-studies-examine-drugs-to-prevent-hiv-associated-opportunistic-infections/
Relative Benefit of ddI and AZT Depends on Duration of Patients' Previous AZT Use
Date: June 10, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/58/relative-benefit-of-ddi-and-azt-depends-on-duration-of-patients-previous-azt-use/
The Effectiveness of AZT Alone, ddC Alone or AZT/ddC Combination Is Similar Overall For Patients with Advanced HIV Disease
Date: June 10, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/59/the-effectiveness-of-azt-alone-ddc-alone-or-azt-ddc-combination-is-similar-overall-for-patients-with-advanced-hiv-disease/
Trial of TAT Antagonist as Therapy for HIV Infection Altered
Date: June 10, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/57/trial-of-tat-antagonist-as-therapy-for-hiv-infection-altered/
ACTG 116B/117: High Levels of AZT Resistance May Predict HIV Disease Progression
Date: June 8, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/54/actg-116b-117-high-levels-of-azt-resistance-may-predict-hiv-disease-progression/
Atovaquone Effective, Well-Tolerated Treatment for AIDS-Related Pneumonia
Date: May 26, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/8/atovaquone-effective-well-tolerated-treatment-for-aids-related-pneumonia/
NIAID Opens Combination Therapy Trial for HIV Infection
Date: May 25, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/7/niaid-opens-combination-therapy-trial-for-hiv-infection/
Partial Results of AZT Study Reported in Lancet
Date: April 2, 1993
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1/partial-results-of-azt-study-reported-in-lancet/
NIAID Launches HIV Therapy Trial of Protease Inhibitor
Date: March 26, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/86/niaid-launches-hiv-therapy-trial-of-protease-inhibitor/
NIAID Begins Study of New Drug for HIV Infection
Date: March 22, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/3/niaid-begins-study-of-new-drug-for-hiv-infection/
Results of Trial of ddI in Patients Intolerant of AZT Announced
Date: February 26, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/26/results-of-trial-of-ddi-in-patients-intolerant-of-azt-announced/
Clinical Alert: Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy
Date: February 1, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/40/clinical-alert-important-therapeutic-information-on-treatment-of-hiv-infection-in-hiv-infected-patients-who-are-intolerant-of-or-have-failed-zidovudine-therapy/
Important Therapeutic Information on Treatment of HIV Infection in HIV-Infected Patients Who Are Intolerant of or Have Failed Zidovudine Therapy
Date: February 1, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/21/important-therapeutic-information-on-treatment-of-hiv-infection-in-hiv-infected-patients-who-are-intolerant-of-or-have-failed-zidovudine-therapy/
Patients' Own Immune Cells Used in Experimental HIV Therapy
Date: January 4, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/85/patients-own-immune-cells-used-in-experimental-hiv-therapy/
FDA Approves New Indication For Dronabinol
Date: December 23, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/12/fda-approves-new-indication-for-dronabinol/
Rifabutin Approval
Date: December 23, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/13/rifabutin-approval/
TMP/SMX Better than Aerosolized Pentamidine for Preventing Recurrent PCP
Date: December 23, 1992
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/88/tmp-smx-better-than-aerosolized-pentamidine-for-preventing-recurrent-pcp/
Multi-Site Trial Begins of the Anti-AIDS Drug, Tat Antagonist
Date: November 30, 1992
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/46/multi-site-trial-begins-of-the-anti-aids-drug-tat-antagonist/
Atovaquone Receives Approval for Treatment of PCP
Date: November 27, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/10/atovaquone-receives-approval-for-treatment-of-pcp/
First AIDS Drug Tested Under Parallel Track Policy; other d4T related press releases
Date: October 5, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/93/first-aids-drug-tested-under-parallel-track-policy;-other-d4t-related-press-releases/
ddI Receives Additional Approval
Date: October 1, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/11/ddi-receives-additional-approval/
Switch To ddI From AZT Appears to Slow Progression of HIV Disease
Date: August 26, 1992
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/18/switch-to-ddi-from-azt-appears-to-slow-progression-of-hiv-disease/
Approval of Zalcitabine
Date: June 22, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/29/approval-of-zalcitabine/
Advisory Committee Recommends Approval of ddC as Combination AIDS Therapy
Date: April 21, 1992
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/32/advisory-committee-recommends-approval-of-ddc-as-combination-aids-therapy/
Early Use of AZT Reduces Risk of Death
Date: April 15, 1992
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/16/early-use-of-azt-reduces-risk-of-death/
Summary of Preliminary Analysis of Study Comparing ddI and ZDV
Date: April 13, 1992
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/45/summary-of-preliminary-analysis-of-study-comparing-ddi-and-zdv/
Study Shows Promise of Fluconazole for Treatment of AIDS-Related Cryptococcal Meningitis
Date: January 8, 1992
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/43/study-shows-promise-of-fluconazole-for-treatment-of-aids-related-cryptococcal-meningitis/
ACTG 106: AZT/ddC Combination Shows Benefits for Patients with Advanced HIV Disease
Date: December 31, 1991
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/42/actg-106-azt-ddc-combination-shows-benefits-for-patients-with-advanced-hiv-disease/
Atovaquone (566C80) Receives Treatment IND Status for AIDS Related Use
Date: November 12, 1991
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/31/atovaquone-(566c80)-receives-treatment-ind-status-for-aids-related-use/
HHS Secretary Louis W. Sullivan announces FDA's approval of ddI.
Date: October 9, 1991
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/35/hhs-secretary-louis-w-sullivan-announces-fdas-approval-of-ddi/
Epoetin Alfa For AIDS Related Condition
Date: January 2, 1991
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/221/epoetin-alfa-for-aids-related-condition/
AZT for Children
Date: May 3, 1990
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/271/azt-for-children/
Expanded Labeling for AZT
Date: March 2, 1990
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/272/expanded-labeling-for-azt/
Approval of AZT
Date: March 20, 1987
Source: Department of Health and Human Services (DHHS)
Author: Public Health Service (PHS)
http://aidsinfo.nih.gov/news/274/approval-of-azt/